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Oligosaccharyltransferase (OST) is a key enzyme of the N-glycosylation pathway, where it catalyzes 
the transfer of a glycan from a lipid-linked oligosaccharide (LLO) to an acceptor asparagine within the 
conserved sequon N-X-T/S. A previous structure of a ternary complex of bacterial single subunit OST, 
PglB, bound to a non-hydrolyzable LLO analog and a wild type acceptor peptide showed how both 
substrates bind and how an external loop (EL5) of the enzyme provided specific substrate-binding 
contacts. However, there was a relatively large separation of the substrates at the active site. Here 
we present the X-ray structure of PglB bound to a reactive LLO analog and an inhibitory peptide, 
revealing previously unobserved interactions in the active site. We found that the atoms forming the N-
glycosidic bond (C-1 of the GlcNAc moiety of LLO and the –NH2 group of the peptide) are closer than in 
the previous structure, suggesting that we have captured a conformation closer to the transition state 
of the reaction. We find that the distance between the divalent metal ion and the glycosidic oxygen of 
LLO is now 4 Å, suggesting that the metal stabilizes the leaving group of the nucleophilic substitution 
reaction. Further, the carboxylate group of a conserved aspartate of PglB mediates an interaction 
network between the reducing-end sugar of the LLO, the asparagine side chain of the acceptor peptide, 
and a bound divalent metal ion. The interactions identified in this novel state are likely to be relevant in 
the catalytic mechanisms of all OSTs.
N-protein glycosylation is a post-translational modification that is conserved in all domains of life1–7. The addition 
of a glycan to a protein can profoundly affect its structure, function, and targeting. In eukaryotes N-glycosylation 
can be important in protein trafficking, cellular signalling or self-non-self interactions1,8,9. In bacteria, including 
the food pathogen Campylobacter jejuni, N-glycans improve host cell- adhesion and colonization, indicating their 
role in virulence5,10.
Although bacteria and eukaryotes display different glycan structures attached to asparagine residues, their 
N-glycosylation pathways are thought to be homologous and follow a conserved mechanism11. The oligosac-
charide is first assembled on a pyrophosphate-lipid carrier and then transferred en bloc to conserved sequons 
(N-X-S/T) of secretory proteins. The reaction is catalyzed by an integral-membrane oligosaccharyltransferase 
(OST). Whereas the OST of higher eukaryotes is a multiprotein complex with STT3 being the catalytic sub-
unit, archaea, kinetoplastids and bacteria have single-subunit OST (ssOST) enzymes that are homologous to 
STT34,12–14. Although OSTs have been found to show some relaxed specificity with respect to the oligosaccharide 
donor, bacterial and archaeal enzymes can transfer a much vaster array of glycans compared to their eukaryotic 
counterparts3,12,15–18.
X-ray structures of ssOSTs of Campylobacter lari (PglB) and Archaeoglobus fulgidus (AglB) have revealed the 
fold of the enzyme13,14,19,20. Extensive in vitro studies and a high resolution structure of PglB bound to a wild type 
peptide and a non-hydrolyzable LLO provided many mechanistic details of peptide and LLO recognition15,16,21–23. 
In particular, it was found that the external loop 5 (EL5), present in all OST enzymes, provided crucial interac-
tions to bound substrates: Whereas the N-terminal half primarily contacted bound LLO, the C-terminal half 
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provided key contacts to bound acceptor peptide. Engagement and disengagement of EL5 appeared essential for 
substrate binding and product release19,23.
Despite the available structural data, the exact mechanism of glycan transfer is not fully understood. For 
example, details of how the substrates interact and how the amido group of the acceptor asparagine is activated, 
are lacking. Specifically, the previously solved ternary complex structure revealed an arrangement of bound sub-
strates that was evidently not very close to the transition state given that the distance between the atoms that 
would form the glycosidic bond was ~6 Å. Here we present the X-ray structure of PglB in complex with an inhib-
itory peptide and a synthetic reactive LLO analog. The structure captures a new intermediate of the glycosylation 
reaction where the substrates are significantly closer, identifying new contacts with conserved residues in the 
catalytic site. The new structural evidence reveals previously unknown interactions between PglB, LLO, acceptor 
peptide and the bound divalent metal ion.
Results
Strategy to trap a distinct ternary complex. Two strategies can in principle be pursued to trap ternary 
complex states of OST (Fig. 1). The first, which was the basis of the previously published structure19, was to 
co-crystallize PglB with wild type peptide (DQNAT(pNO2-F)) and a non-hydrolyzable, phosphonate-containing 
LLO analog (ωZZZ-PPCH2-GlcNAc). DQNATF is an optimal acceptor sequon for C. jejuni PglB and the phos-
phonate-containing LLO analog was identified as a competitive inhibitor (Fig. 1)14,19,24. In the resulting ternary 
complex structure we found that the phosphonopyrophosphate group was not coordinated by the catalytic Mn2+ 
ion and that the substrates were distantly located (~6 Å apart). We hypothesized that this gap was due to the use 
of a phosphonopyrophosphate rather than a pyrophosphate group and that using a reactive LLO might reveal a 
bound state closer to the transition state of the reaction. We therefore pursued a second strategy to form a ternary 
complex by incubating PglB with a functionally competent, synthetic LLO analog and an inhibitory peptide 
(Fig. 1). We chose 2,4-diaminobutanoic acid (Dab) to replace the acceptor asparagine, because Dab-containing 
peptides were previously shown to act as competitive inhibitors of bacterial and eukaryotic OSTs at physiological 
pH (Fig. 1A)21,25,26. We investigated whether the Dab-containing peptide and the functional LLOs showed activity 
with PglB at pH values used to crystallize it (pH ~8.9) and did not detect any glycosylation of the Dab-containing 
peptide, demonstrating that no glycan transfer occurs even after very long incubations. We therefore used this 
Dab-containing peptide for crystallization experiments. We used the reactive synthetic LLO analog ωZZZ-PP-
GlcNAc, which is chemically very similar to the wild type LLO except that it contains a GlcNAc rather than di-N-
acetyl-bacillosamine as a reducing-end sugar (Fig. 1)19. This LLO compound exhibited the highest turnover rate 
of all of the water-soluble synthetic LLO analogs tested19,27. The resulting ternary complex was crystallized and the 
structure determined at 3.4 Å resolution (Fig. 2 and Table 1).
LLO binding and the role of Mn2+. Whereas the overall structure of PglB bound to the reactive LLO and 
inhibitory peptide is very similar to the previously determined ternary complex, there are important differences 
(Fig. 2, Supplementary Fig. 1)19. The key difference is that the two substrates are closer in the new ternary com-
plex, with a distance of ~3.4 Å between carbon C-1 of the GlcNAc moiety of reactive LLO and the –NH2 group of 
the Dab residue, representative of the atoms that would form an N-glycosidic bond if Dab was replaced by Asn. In 
contrast, the equivalent distance between the GlcNAc of non-reactive LLO and the acceptor asparagine was ~6 Å 
in the previously determined structure19. The closing of the distance is mainly due to a shift of the reducing-end 
GlcNAc and is probably due to new contacts formed. Whereas the lipid tail of the LLO analog has an indistin-
guishable conformation to the previous ternary complex, the pyrophosphate and GlcNAc moieties have shifted 
and interact differently with the surface of PglB in the new structure (Fig. 3). We now observe continuous electron 
density between the pyrophosphate group of LLO and the catalytic Mn2+, with the shortest distance (~4  Å) 
observed between Mn2+ and the oxygen linking C1 of GlcNAc and the pyrophosphate moiety (Fig. 3A, 
Supplementary Fig. 2). This indicates that the divalent metal ion, instead of being coordinated by water molecules, 
interacts with the pyrophosphate group. The structure also revealed different interactions between the pyrophos-
phate of the LLO and two essential catalytic residues, R375 and Y196. They appear to form hydrogen bonds with 
both phosphate groups, not just with the phosphate directly attached to the GlcNAc, as was observed for the ter-
nary complex with non-reactive LLO (Fig. 3). This may explain why mutation of either of these residues to alanine 
abolished the glycosylation activity of PglB, but not binding of acceptor peptide19,22. Our structure also revealed 
contacts between the reducing-end sugar and PglB that were not observed before. In the previous ternary com-
plex, the N-acetyl group of the reducing-end GlcNAc was at a distance of ~3.1 Å from Y468 but was not close 
enough to interact with D56 (distance of 5.2 Å). In the present structure, the N-acetyl group can form hydrogen 
bonds with the side chains of both D56 and Y468. The carbonyl oxygen is placed at a distance of 2.2 Å from the 
hydroxyl oxygen of Y468, whereas the nitrogen is at a distance of 3.3 Å from the carboxyl group of D56. Both D56 
and Y468 have previously been demonstrated to be essential for PglB activity, but D56 was only shown to be 
involved in Mn2+ coordination and peptide binding14,19. Because both D56 and Y468 are strictly conserved cata-
lytic residues, the newly identified interactions are likely relevant for all OST enzymes.
Mobility of the reducing-end GlcNAc in the catalytic site. The electron density for the lipid tail and 
the pyrophosphate group of reactive LLO was stronger than that for the GlcNAc moiety, unlike in the previous ter-
nary complex with non-reactive LLO where the quality of the density for the LLO was similar throughout19. This 
suggests that either the sugar moiety of the reactive LLO molecule is more mobile, or that the LLO may have been 
hydrolyzed in the crystallization conditions, which would result in a mixture of LLO and lipid-pyrophosphate. 
Both PglB and yeast octameric OST were previously reported to exhibit hydrolytic activity and produce free 
oligosaccharides (fOS) in the absence of the acceptor sequon28–30. We therefore tested the stability of LLO by incu-
bating it in crystallization conditions in the presence of PglB and the presence or absence of Dab peptide. We then 
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quantified the amount of LLO left using an in vitro glycosylation assay, where the samples were diluted and incu-
bated with freshly purified PglB and an excess of fluorescently labeled wild type peptide over LLO (Fig. 4A)19,21,22. 
We did not detect any loss of LLO in the crystallization conditions over a period of 48 hours, which suggests that 
the intact LLO analog, and not its hydrolyzed derivative, are present in the co-crystal (Fig. 4B). The discrepancy 
between our results from in vitro experiments and previous studies remains unresolved28,29. Because there is no 
LLO hydrolysis in our experiment, the slightly weaker density for GlcNAc could be explained by an increased 
mobility of the GlcNAc moiety of the reactive LLO. We speculate that for wild type heptasacccharide-containing 
LLO the presence of extra sugar moieties would form additional interactions with PglB, likely decreasing the 
mobility of the reducing-end sugar.
Figure 1. Strategies to trap distinct intermediate states of the PglB-catalyzed glycosylation reaction. (A) 
Structure of the substrate and inhibitory peptides used in crystallization experiments. The red ‘R’ denotes a 
side chain of either asparagine or 2,4-diaminobutanoic acid (Dab). (B) Structure of the synthetic LLO analogs 
used in crystallization experiments. The blue ‘X’ denotes the linkage between C-1 of the GlcNAc moiety and 
the phosphorous atom of the first phosphate group. (C) Schematic of two strategies pursued to trap ternary 
complexes of PglB using different peptide and LLO analogs. Top: method used previously to co-crystallize PglB 
with a wild type peptide and a non-hydrolyzable LLO analog (iLLO)19. Bottom: method used in this study to 
co-crystallize PglB with an inhibitory, Dab-containing peptide and a reactive LLO analog. The outline of C. lari 
PglB in a detergent micelle is shown in grey, peptide in orange and the LLO analogs are represented by a blue 
square for the N-acetyl-glucosamine (GlcNAc) moiety, a black ‘P’ for the phosphate group and a gold line for the 
lipid tail. The non-hydrolyzable LLO analog and the inhibitory peptide are marked with a pink ‘C’ and a red ‘X’, 
respectively.
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Binding of the inhibitory peptide. The position of the backbone of the inhibitory peptide is unaltered 
relative to that of the wild type peptide in the previous ternary complex, validating the use of the Dab-containing 
peptide as a substrate mimic19. The Dab side chain reaches the catalytic site where it can form hydrogen bonds 
with three conserved and catalytically essential residues, the side chains of D56 and E319 and the main chain 
Figure 2. Structure of the ternary complex with inhibitory Dab peptide and reactive LLO. (A) cartoon 
representation of PglB with the transmembrane domain colored in light blue, periplasmic domain in light 
green, and N-terminal and C-terminal part of EL5 in turquoise and dark red, respectively. The LLO and Dab 
peptide are shown as yellow and orange spheres, respectively. (B) Close-up view of the PglB active site. EL5 was 
removed for clarity. The LLO and Dab peptide are shown as yellow and orange sticks and the divalent metal ion 
in pink. A polder omit map contoured at 4.0 σ around bound Dab peptide is shown as green mesh. (C) close-up 
view of the PglB active site rotated 40 ° relative to that in B. A polder omit map contoured at 4.0 σ around bound 
LLO is shown as green mesh. The Dab peptide is shown as ribbon.
Ternary complexa
Data collection
Space group P212121
Cell dimensions
  a, b, c (Å) 83.81, 116.54, 173.89
  α, β, γ (°) 90.0, 90.0, 90.0
Resolution (Å) 40.74–3.40 (3.49–3.40)*
Rmeas 0.069 (1.44)*
I/σ 23.25 (1.95)*
CC1/2 0.999 (0.676)*
Completeness (%) 92.1 (36.7)*
Redundancy 12.4 (4.8)*
Refinement
Resolution (Å) 40.74–3.40
No. reflections 24002 (2377)*
Rwork/Rfree 0.2492/0.2831
No. non hydrogen atoms 5931
  Protein 5866
  Ligands 65
B-factors (Å2)
  Protein 110.17
  Ligands 103.73
R.m.s. deviations
  Bond lengths (Å) 0.008
  Bond angles (°) 1.13
Table 1. Data collection and refinement statistics (molecular replacement). Values shown correspond to 
statistics after anisotropy correction. aData collected from one crystal. *Values in parentheses are for highest-
resolution shell.
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Figure 3. Interactions between PglB and bound LLO (A) Schematic of the interactions. Periplasmic, 
transmembrane and EL5 residues are shown in green, blue and red, respectively, and labeled. The acceptor 
peptide is shown in orange. The conserved R375 and Y196 residues interact with both phosphate groups. A 
previously unobserved interaction between the side chain of D56 and the N-acetyl group of the GlcNAc moiety 
is suggested by the structure. (B) Stereo view of the superposition of both ternary complexes. The new ternary 
complex PglB–LLO–Dab-peptide is shown in light brown with the reactive LLO and inhibitory Dab peptide 
shown in orange and yellow sticks, respectively. The previously reported ternary complex (PDB 5OGL) is 
shown in blue with the non-hydrolyzable LLO analog (iLLO) and WT acceptor peptide shown in cyan and dark 
blue sticks, respectively. The divalent metal ion is shown as a pink sphere. The black dashed line represents the 
distance between the reactive LLO and the amino group of the Dab residue. (C) Stereo view of the LLO binding 
site rotated 90° relative to that of B. The conserved residues in the catalytic site are shown as sticks. The GlcNAc 
moiety is positioned closer to the Mn2+ ion and residue D56.
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carbonyl oxygen of G482 (Fig. 3 and Supplementary Fig. 2)14,21,22,31. It was previously shown that replacing the 
acceptor asparagine with Dab resulted in a 10- fold decrease in peptide affinity21. This suggests that the presence 
of the carbonyl oxygen in the acceptor asparagine side chain, and the absence of a charge on the –NH2 group, 
produce favourable interactions with the enzyme that contribute to the binding affinity but also allow glycan 
transfer. However, when comparing the Dab-peptide- to the wild type-peptide-bound structure of PglB, there are 
no specific interactions (hydrogen bonds) between PglB and the carbonyl group of the acceptor asparagine that 
would contribute significantly to the increased peptide affinity, as only van der Waals interactions are observed 
(Fig. 3B)19. The exact chemical mechanism of increased binding and transfer activity, and the precise reason for 
why Dab is inhibiting, are therefore unknown.
Discussion
The ternary complex presented here provides a first structural view into how OST interacts with a reactive LLO 
molecule. The captured intermediate is closer to the transition state of the glycosylation reaction than the pre-
vious ternary complex, because we observe an interaction between the pyrophosphate group of LLO and the 
Mn2+ ion, and the C-1 of GlcNAc is closer to the Dab side chain of the peptide than to the amide nitrogen 
in the previous structure19. The new structure also provides direct evidence that one of the roles of the diva-
lent metal ion is the stabilization of the pyrophosphate, the leaving group of the substitution reaction. Similar 
roles were attributed to divalent metal ions in other glycosyltransferases (GTs) and were expected/predicted for 
OST22,32–35. Unexpectedly, however, the Mn2+ ion seems to be coordinated by the glycosidic oxygen atom rather 
than the negatively charged phosphate oxygens as observed in structures of GT-A superfamily members32. This 
suggests that the divalent metal ion might directly activate the glycosidic oxygen during the reaction by gener-
ating a reactive electrophile. This could compensate for the poor nucleophilicity of the carboxamide group of 
the acceptor asparagine and might even allow glycan transfer without amide activation. This hypothesis is in 
line with the observed inhibitory effect of Dab-containing peptides that cannot be glycosylated in vitro, which is 
probably due to the absence of a free electron pair in the protonated form. In contrast, it has been shown that a 
homoserine-containing peptide, which has the same number of methylene groups and therefore the same side 
chain length as Dab, is O-glycosylated21. The hydroxyl group of the homoserine analog, unlike the protonated 
Dab side chain, readily provides free electron pairs that can act as a nucleophile during the substitution reaction.
An N-acetyl group at the C-2 position of the reducing-end sugar is highly favoured by PglB and is strictly 
required for glycan transfer in eukaryotic OSTs1,11,12,15,36,37. Biochemical studies of yeast OST showed that minor 
modifications to this substituent, such as replacement of hydrogens with fluorines, reduced LLO binding and 
abolished glycosylation activity probably because the electron-withdrawing trifluoromethyl group made the 
neighbouring carbonyl oxygen a less efficient hydrogen bond acceptor16. The new ternary complex of PglB reveals 
hydrogen bonding interactions between the N-acetyl group of LLO and residues D56 and Y468 in the catalytic 
Figure 4. Stability of LLO at buffer conditions used for crystallization. (A) Schematic representation of the in 
vitro assay used to verify the stability of the reactive LLO in the crystallization conditions. LLO was incubated 
with PglB for 48 h at 20 °C in the presence or absence of Dab peptide and the amount of LLO was quantified. As 
a control, non-incubated LLO was used. (B) Quantification of the reactive LLO using an in vitro glycosylation 
assay. Data represents technical replicates and error bars indicate s.d. (n = 3).
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site of PglB. Because D56 also interacts with the acceptor peptide and the bound divalent metal ion, modification 
of the N-acetyl substituent is likely to affect the entire hydrogen bonding network, impairing glycan transfer16.
Although the new ternary complex reveals novel interactions, future functional and molecular dynamics stud-
ies are required to give insight into the exact role of the divalent metal ion in activation of the glycosidic oxygen 
of LLO. The recent cryo-EM structures of eukaryotic octameric OSTs revealed that the fold and key side chains of 
the catalytic STT3 subunit are conserved, demonstrating that PglB is an excellent model system to study the gly-
cosylation reaction19,37–39. The structure presented here is therefore likely to prove valuable for future mechanistic 
interpretations not only of bacterial ssOSTs, but of OSTs from all domains of life.
Materials and Methods
Overexpression and purification of PglB. Overexpression and purification of PglB was performed as 
previously described19. Briefly, PglB was overexpressed in Escherichia coli BL21-Gold cells (DE3) (Strategene) 
at 37 °C in five-liter flasks using Terrific Broth medium supplemented with 1% glycerol (w/v). The cells were 
induced at 37 °C for 4 h at A600 of 3.0 by adding 0.1% arabinose (w/v). All following steps were carried out at 4 °C. 
Cells were harvested by centrifugation. Cells were resuspended in 25 mM Tris-HCl, pH 8.0, 250 mM NaCl and 
disrupted in a M-110-l microfluidizer (Microfluidics) at 15,000 p.s.i. chamber pressure. Membranes were pelleted 
by centrifugation at 100,000 g for 30 min and solubilized in 25 mM Tris-HCl, pH 8.0, 250 mM NaCl, 10% glycerol 
(v/v) and 1% N-dodecyl-β-D-maltopyranoside (w/v) (DDM, Anatrace) for 1.5 h. All subsequent purification 
buffers contained 0.016% DDM. PglB was purified on a nickel-nitrilotriacetic acid (Ni-NTA) Superflow affinity 
column (Qiagen) and desalted into 10 mM MES, pH 6.5, 100 mM NaCl, 3% glycerol (v/v), and 0.016% DDM. For 
crystallization experiments, desalted protein was concentrated to 6 mg mL−1 in an Amicon Ultra-15 concentrator 
(Milipore) with a molecular mass cutoff of 100 kDa and purified by size exclusion chromatography (Superdex 
200 10/300, GE Healthcare) in desalting buffer. Collected fractions were pooled and concentrated to 12 mg mL−1.
Protein crystallization. Ac-DQ(Dab)ATF(p-NO2)-NH2, nerylneryl-PP-GlcNAc and MnCl2 were added 
to the concentrated protein to the final concentration of 0.75 mM, 1.5 mM, 2 mM, respectively and incubated for 
15 min at 4 °C. PglB was crystallized by vapor diffusion in hanging drops at 20 °C against a reservoir containing 
100 mM glycine, pH 9.4, 50–200 mM magnesium acetate, and 27–31% PEG400 at the protein-to-reservoir ratio 
2:1. Crystals usually appeared after 10–14 days and grew to full size within 3–4 weeks. Crystals were cryopro-
tected by stepwise addition of cryoprotectant PEG400 up to 30% final concentration and directly flash frozen in 
liquid nitrogen before data collection.
Data collection and structural determination. The X-ray data was collected at the microfocus X06SA 
beamline at the Swiss Light Source (Villigen). The wavelength for data collection was 1.000 Å. All data were pro-
cessed using XDS package40. Ellipsoidal truncation and anisotropic correction were applied to the data using the 
diffraction anisotropy server41. The ternary complex crystallized in the P212121 space group, containing one PglB 
molecule per asymmetric unit. The structure was solved by molecular replacement using PDB 5OGL as a model. 
The iterative model building and refinement was performed in Coot42 and Phenix43. Final refinement statistics 
and data collection are summarized in Table 1. Structural figures were drawn using PyMOL44.
Quantification assay. LLO and PglB were incubated in the presence or absence of Dab peptide for 48 h at 
20 °C. The mixture conditions replicated the crystallization conditions, where 10 mg mL−1 PglB, 1.5 mM LLO 
(nerylneryl-PP-GlcNAc), 0.75 mM inhibitory peptide (Ac-DQ(Dab)ATF{p-NO2}-NH2) in 10 mM MES pH 6.5, 
3% glycerol, 100 mM NaCl, 0.016% DDM was added to 100 mM glycine pH 9.4, 28% PEG 400, 200 mM mag-
nesium acetate in 2:1 ratio. The samples were diluted and the LLO was quantified against fluorescently labeled 
wild type peptide (DQNATF). The LLO dilutions were incubated for 12 h at 25 °C with 10 µM labeled peptide 
and purified protein in reaction buffer containing 10 mM MES pH 6.5, 100 mM NaCl, 3% glycerol 0.016% 
DDM, 10 mM MnCl2. The samples were analyzed by in-gel fluorescence and the ratio between glycosylated 
and non-glycosylated peptide was calculated using ImageJ. The concentration of LLO was determined in reac-
tions where the wild type peptide was always present in excess over LLO. Data was fitted by linear regression in 
GraphPad PRISM 7.0.
Synthesis of nerylneryl-PP-GlcNAc ((ωZZZ)-PP-GlcNAc)). The nerylneryl-PP-GlcNAc 
((ωZZZ)-PP-GlcNAc) analog was synthesized according to previously reported procedures19,27. The synthetic 
strategy included three steps: the synthesis of GlcNAc α-phosphate, preparation of the nerylneryl-phosphate 
precursor, and finally the coupling of both monophosphates to the desired final pyrophosphate. 
Nerylneryl-PP-GlcNAc was shown to be pure by 1H, 13C, 31P NMR and ESI-HRMS.
Data Availability
Atomic coordinates were deposited in the Protein Data Bank under the accession code: PDB 6GXC.
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